At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
The new online Learning Center with new content can still be found under the “Training” folder on ...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...